Historical record - last NADAC effective date: 10/21/2020
Product Information
OXYMORPHONE HCL ER 40 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $15.4795 per EA under NDC 00115123401. Its NADAC has been published 392 times since Nov 28, 2013.
FDA first approved this application on Jun 14, 2010.
Strength
40 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115123401
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
10/21/2020
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079087FDA Approved
6/14/2010
On Market Since
1/2/2013
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL ER 40 MG TAB has been published 392 times since Nov 28, 2013, and over the history we have for it it has risen 81.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4795 per EA |
|---|---|
| All-time high | $15.4795 (May 26, 2021) |
| All-time low | $7.3230 (Mar 18, 2015) |
| Median price | $8.6736 |
| Average price | $9.8162 |
| Largest weekly change | +28.9% (Mar 23, 2016) |
| Weeks tracked | 392 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+81.9%
Last surveyed May 26, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxymorphone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL ER 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL ER 40 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $15.4795 per EA (NDC 00115123401), effective May 26, 2021.
How has the price of OXYMORPHONE HCL ER 40 MG TAB changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL ER 40 MG TAB has risen 81.9%. It has been tracked across 392 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL ER 40 MG TAB?
Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL ER 40 MG TAB has ranged from a low of $7.3230 (Mar 18, 2015) to a high of $15.4795 (May 26, 2021), with a median of $8.6736 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL ER 40 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYMORPHONE HCL ER 40 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYMORPHONE HCL ER 40 MG TAB?
OXYMORPHONE HCL ER 40 MG TAB (NDC 00115123401) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.